Supporting Healing ♦ Teaching ♦ Research
News
20-Oct-2010
Hadassah’s Cell Cure Neurosciences Ltd. has entered into an exclusive license option agreement with Teva Pharmaceutical Industries to develop and commercialize OpRegen™, Hadassah’s stem-cell product for the treatment of Age-related Macular Degeneration (AMD). Cell Cure is a subsidiary of Hadasit Bio Holdings, the Hadassah Medical Center’s technology transfer company, and BioTime, Inc.
20-Oct-2010
Israel’s Ministry of Health has given approval for the Hadassah Medical Center and BrainStorm Cell Therapeutics Inc., the leading developer of stem cell technologies, to partner for a clinical trial of BrainStorm’s stem cell treatment for Amyotrophic Lateral Sclerosis (ALS) at Hadassah.
8-Oct-2010
With the message, “This Year on Rosh Hashana (the Jewish New Year) Give the Gift of Life,” Hadassah Panama raised $15,000 for the Hadassah Medical Center Blood Bank.
8-Oct-2010
This past summer, Mexican Entrepreneur Sion Soffer consulted with Hadassah Medical Center Director General Prof. Shlomo Mor-Yosef in Jerusalem to begin planning for the development of trauma facilities in Mexico City.
8-Oct-2010
Young Hadassah International announces its annual weekend, this year held in the captivating capital of Austria, Vienna, known for its rich culture and highest quality of life. The "Weekend in Vienna" will unite young professionals from around the world in support of the Hadassah Medical Organization. Participants will learn about the latest developments in medical treatments and research from Hadassah doctors and share ideas on how to contribute to its progress, which impacts communities in Israel and around the world.
8-Oct-2010
Connect with Hadassah International friends all over the globe on the Hadassah International Facebook page. Click here for instructions.
7-Oct-2010
When the large brain aneurysm of a 35-year-old patient doubled in size in ten days, Endovascular Neurosurgeon and Interventional Neuroradiologist Prof. José Cohen and his colleagues in the Department of Neurosurgery at Hadassah Hospital-Ein Kerem pioneered a new technique to save his life.
7-Oct-2010
The Director General of the International Atomic Energy Agency (IAEA), Mr. Yukiya Amano, was hosted by Hadassah Medical Center Director General Prof. Shlomo Mor-Yosef and Prof. Tamar Peretz, Director of Hadassah’s Sharett Institute of Oncology, during an August visit to the Medical Center. Mr. Amano was introduced to the activities of Hadassah scientists and physicians in the field of cancer treatment, including nuclear medicine. When he later met with President Shimon Peres, Mr. Amano said that he was "impressed by Hadassah's abilities, which were a good example of the employment of nuclear technology for peaceful goals."
7-Oct-2010
During the last week in August, Hadassah Australia hosted four major health initiatives, which addressed crucial health concerns facing both its local communities in Melbourne and Sydney and the global community. Three of the four events dealt with neonatal male circumcision as a means to prevent the spread of HIV/AIDS; the fourth was a workshop on best practices to advance global health conducted by Hadassah Australia and Monash University at the 63rd Annual United Nations Department of Information/Nongovernmental Organization Conference. (See article on UN Conference in this issue of the eBulletin.)
7-Oct-2010
Hadassah Australia, in partnership with Melbourne’s Monash University, presented a workshop entitled “Sharing Best Practice to Advance Global Health” at the 63rd United Nations Department of Public Information/NonGovernmental Organization (NGO) Conference on August 31.